Skip to content
Open access

Clinical outcomes associated with recurrent compared to first-time myocardial infarction.

Aug 2026 · American Heart Journal · pp. 107592 · 0 citations · 43 references
Medicine

TL;DR

Recurrent MI is associated with a higher risk of all-cause mortality, hospitalization for heart failure, HHF, and further recurrent MI compared with first-time MI.

Abstract

Background

Patients with recurrent myocardial infarction (MI) are a heterogenous group with high comorbidity burden, risk of complex coronary disease, and at risk of poor outcomes. However, contemporary comparative data are lacking.

Methods

Consecutive patients with recurrent MI (defined as a new hospital admission for MI >28 days following a first-time MI) in Denmark between 2015 and 2022 were identified through the nationwide registries and matched 1:1 on age and sex to patients with first-time MI. The primary outcome was a composite of all-cause mortality, hospitalization for heart failure (HHF), and further recurrent MI. Standardized risks with 95% confidence intervals (CI) were estimated using cause-specific Cox regression models with first-time MI serving as the reference group.

Results

A total of 8,397 patients with recurrent MI and 8,397 with first-time MI were included (median age 73, 70.7% male). Patients with recurrent MI had more comorbidities. For the primary composite outcome, patients with recurrent MI had a standardized 1-year risk of 24.0% versus 17.2% among those with first MI (standardized risk ratio [sRR] 1.39 [95% CI: 1.34-1.44]). They also had higher risks of: all-cause mortality, 14.6% versus 11.3% (sRR 1.29 [1.24-1.35]); HHF, 6.6% versus 6.0% (sRR 1.11 [1.00-1.21]), and recurrent MI 6.7% versus 2.2% (sRR 3.01 [2.71-3.45]). Use of guideline-recommended treatments post-dicharge was high, albeit lower than for first-time MI: percutaneous coronary intervention (53.7% versus 64.3%, p<0.001), lipid-lowering treatment (78.1% versus 83.2%, p<0.001), and P2Y12 inhibitor (77.3% versus 82.6%, p<0.001).

Conclusion

Recurrent MI is associated with a higher risk of all-cause mortality, HHF, and further recurrent MI compared with first-time MI.

Read PDF

Similar papers

Open access Oct 2026

Clinical characteristics and in-hospital prognostic factors in young patients with myocardial infarction

Objectives This study aims to analyze the clinical characteristics and short-term prognostic factors of young patients with acute myocardial infarction. Methods This retrospective observational study included young patients (aged 18 to 45 years) who visited our center for AMI from January 1, 2014, to October 31, 2023....

Jin-Xuan Lin, Yong-Fang Liao, Ting-Rong Liu et al. · 0 citations
Aug 2026

Incidence, Predictors, and Clinical Impact of Early Readmission After Complex Percutaneous Coronary Intervention.

It is concluded that early rehospitalization after complex PCI is associated with worse 1-year outcomes, and clinical and procedural predictors - including sex-specific differences - should inform risk mitigation strategies to optimize post-PCI care.

F. Kalaba, Y. Garg, C. Odukwe et al. · 0 citations
Sep 2026

[Predictive factors of recurrent acute coronary syndrome].

Diabetes, inflammation, and multi-stenting were independently associated with recurrence of acute coronary syndrome, highlighting the importance of strict management of metabolic and inflammatory factors, as well as the optimization of revascularization strategies.

K. Chalbi, A. Chetoui, S. Neji et al. · 0 citations
Sep 2026

Contemporary invasive management and in-hospital outcomes of acute myocardial infarction in patients with active or prior cancer: insights from the EYESHOT-2 registry.

Cancer status was not significantly associated with non-performance of PCI after multivariable adjustment in either STEMI or NSTEMI, and mortality and bleeding comparisons were unadjusted and limited by small cancer subgroups and few events.

Alessandra Greco, I. Bisceglia, M. Canale et al. · 0 citations
Open access Aug 2026

Outcome evaluation of percutaneous coronary intervention vs medical therapy alone in patients with chronic coronary syndrome

Among CCS patients diagnosed non-invasively, the medication-only group demonstrated comparable all-cause mortality and MI rates, but a significantly lower risk of revascularization compared with the PCI group, while incurring only onethird of the healthcare costs.

Hsien-Yuan Chang, Hsin-Yu Fang, Mu-Shiang Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.